This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Skates, S. Articles by Iliopoulos, O. Search for Related Content PubMed PubMed Citation Articles by Skates, S. Articles by Iliopoulos, O.

Molecular Markers for Early Detection of Renal Carcinoma

Investigative Approach

¹ Biostatistics Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, and ² Hematology-Oncology Unit, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Molecular markers for renal cell carcinoma could guide early detection of localized disease in defined populations at high risk for the disease or early disease recurrence after nephrectomy for renal cell carcinoma. In addition, sensitive and specific markers may provide surrogate end points for clinical trials of treatment and/or disease prevention. Powerful techniques of genomic and proteomic analysis of human renal carcinoma cell lines, tumor samples, and biological fluids, such as plasma and urine, obtained from patients with renal cell carcinoma, are likely to identify candidate markers. Careful selection among early candidate markers and further testing in independent patient populations are required for marker validation.

This article has been cited by other articles:

				N. Mumoli, M. Cei, J. K. Kim, and K.-S. Cho Molecular Markers, Paraneoplastic Syndrome, and Inferior Vena Cava Involvement as Risk Factors for Renal Tumor Recurrence * Drs Kim and Cho respond: Radiology, August 1, 2005; 236(2): 739 - 739. [Full Text] [PDF]